Skip to Content
Søg Menu

ASCO GI 2024 | Gastrointestinal Cancers Symposium

ASCO GI 2024

Anant Ramaswamy

Adding Docetaxel to FOLFOX/CAPOX in Gastric and Gastroesophageal Adenocarcinomas Does Not Improve Survival

/ Anant Ramaswamy
ASCOGI24Gastrointestinal cancer Play the Video

Få adgang til alle artikler, MEDtalks, MEDcasts og meget mere

Som læge, sygeplejerske eller anden sundhedsfaglig kan du få online adgang og modtage magasiner gratis, når du har tilmeldt dig og er blevet godkendt som bruger.

Få adgang
Thierry André

Nivolumab plus Ipilimumab – A Potential New Standard-of-Care Treatment Option for Patients with MSI-H/dMMR Advanced Metastatic Colorectal Cancer

/ Thierry André
ASCOGI24Colorektalcancer Play the Video
Laurids Østergaard Poulsen

Highlights fra ASCO GI 2024: Immunterapi, cirkulerende tumor DNA og total neoadjuverende behandling

/ Laurids Østergaard Poulsen
ASCOGI24Colorektalcancer Play the Video
Nicole Serapin

The Impact of COVID-19 on the Stage at Presentation for Colorectal Cancer Patients

/ Nicole Serapin
ASCOGI24Colorektalcancer Play the Video
Kohei Shitara

CheckMate 649’s Four-Year Survival Data on Chemo + Nivolumab for Gastric & Esophageal Cancer

/ Kohei Shitara
ASCOGI24Gastrointestinal cancer Play the Video

ASCO GI 2024: Targeting HER2 in Gastroesophageal Adenocarcinoma

/ Sofie Pohl
ASCOGI24Gastrointestinal cancerBrystcancer
Kohei Shitara

Management of Nausea and Vomiting Following First-Line Zolbetuximab + Chemotherapy

/ Kohei Shitara
ASCOGI24Gastrointestinal cancer Play the Video

Meta Analysis of Three Trials: FAST, SPOTLIGHT & GLOW Exploring the New Target Claudin 18.2 in Gastric Cancer

/ Davi Said Gonçalves Celso
ASCOGI24Gastrointestinal cancer Play the Video
Yelena Janjigian

Global Insights from MATTERHORN: Unifying Gastric Cancer Treatment Standards with Durvalumab and FLOT

/ Yelena Janjigian
ASCOGI24Gastrointestinal cancer Play the Video
Van Morris

Circulating Tumor DNA – A Biomarker for Adjuvant Chemotherapy?

/ Van K. Morris
ASCOGI24Tarmcancer Play the Video
Per Pfeiffer

Immunterapi som alternativ til traditionel behandling ved rektumcancer?

/ Per Pfeiffer
ASCOGI24ColorektalcancerImmunterapi Play the Video
Yun Sung

Survival Outcomes in Patients with Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy (TNT)

/ Yun Song
ASCOGI24Gastrointestinal cancer Play the Video
Hent flere

ASCO GI 2023

Laurids Poulsen

ASCO GI 2023 om colorektalcancer – I et dansk perspektiv

/ Laurids Østergaard Poulsen
ASCOGI23 Play the Video
Wungki Park

First-line treatment of claudin 18.2-positive metastatic pancreatic cancer with zolbetuximab, gemcitabine, and nab-paclitaxel

/ Wungki Park
ASCOGI23Pancreascancer Play the Video
Wungki Park

New potential standard-of-care for patients with CLDN18.2+/HER2- LA unresectable or mG/GEJ adenocarcinoma – an international perspective

/ Wungki Park
ASCOGI23HER2 Play the Video
Ken Kato

New option for 1. line treatment of advanced oesophagal squamous cell carcinoma – 29. Month Follow-up

/ Ken Kato
ASCOGI23Esofaguscancer Play the Video
Kohei Shitara

Promising Effect of Zolbetuximab and mFOLFOX6 Combination For Gastroesophageal Junction Adenocarcinoma

/ Kohei Shitara
ASCOGI23EsofaguscancerVentrikelcancer Play the Video
Stacey Cohen

No significant impact of plasma cfDNA levels on ctDNA detection rates across different MRD in patients with colorectal cancer

/ Stacey Cohen
ASCOGI23Colorektalcancer Play the Video
Laura Dawson

Positive effect of stereotactic body radiation therapy (SBRT) followed by sorafenib in patients with hepatocellular carcinoma

/ Laura Dawson
ASCOGI23Levercancer Play the Video
Josep Tabernero

New treatment option for refractory metastatic colorectal cancer – trifluridine/tipiracil plus bevacizumab

/ Josep Tabernero
ASCOGI23Colorektalcancer Play the Video

Late Breaking: Patients with Advanced Biliary Tract Cancer Can Safely be Treated with Antibiotics and Continue Treatment with ICI

/ BestPractice Nordic
ASCOGI23Galdegangscancer

Late Breaking: Zolbetuximab + Chemo as New Potential Standard Treatment for Patients with Unresectable, Metastatic Gastric, or Gastro-Esophageal Junction Adenocarcinoma

/ BestPractice Nordic
ASCOGI23EsofaguscancerGastrointestinal cancerVentrikelcancer

Noteworthy Studies Exploring New Approaches in the Treatment and Management of Gastrointestinal Cancers

/ BestPractice Nordic
ASCOGI23Gastrointestinal cancerVentrikelcancer

ASCO Gastrointestinal Cancers Symposium Celebrates 20 Years of Innovative and Transforming Care to Advance GI Cancer Treatment

/ BestPractice Nordic
ASCOGI23Gastrointestinal cancer
Back to top